Vivian Wei Cheng recognised by IAM patent 1000 2023
The 2023 edition of IAM Patent 1000 2023 has recognised Vivian Wei Cheng as one of the world’s foremost practitioners in the area of prosecution.
Can patent term be extended in ASEAN countries?
In this article, patent attorney Vivian Wei Cheng discusses patent term extension in the association of Southeast Asian nations (ASEAN), a globally important group.
How to salvage a patent in view of disclosure-grace periods in Asia Pacific countries
The grant of a 20-year exclusive monopoly on a patented invention to a patent proprietor is done so in exchange for a full disclosure of the novel and inventive invention and how it may be worked.
Singapore: Key IP statutes changes – Intellectual Property (Amendment) Act 2022
The Intellectual Property (Amendment) Bill is expected to come into effect in May 2022, introducing amendments to a host of current IP acts. We outline the various changes, detailing what these could mean for improving operational efficiency, and legislative and procedural clarity, for business registering IP assets in Singapore
Key IP statutes changes – Intellectual Property (Amendment) Act 2022
On 12 January 2022, the Intellectual Property (Amendment) Bill was passed in Parliament and is expected to come into effect in May 2022.
Medical use claims in Asia Pacific region – The key differences you need to know
The Asia Pacific region is a significant emerging patent market for pharma companies. Our latest article explores the key differences to note in how medical use claims may be construed in various jurisdictions in the region.
Singapore patent law updates: Pre-grant third party observations of patent applications and post-grant re-examination of patents
In Singapore, amendments have been introduced to the Singapore Patent Rules from 1 October 2021 to formalise pre-grant third party observations and to introduce post-grant re-examination, with an aim to enhance dispute resolution processes.
Singapore High Court has no original jurisdiction to revoke a patent
For years, defendants in patent infringement proceedings have brought counterclaims for revocation of the patent. However, a recent High Court judgment indicates that this is no longer possible.
The Singapore Court of Appeal Rules on Post Grant Amendments to Patents and Validity of Second Medical Use Claims
On 1 August 2017, the Singapore Court of Appeal in Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd [2017] SGCA 45 dismissed Warner-Lambert’s application to amend its patent for the use of pregabalin for the treatment of pain (the “Patent”).
Proposed changes to Singapore patent system
The Singapore Government and the Intellectual Property Office of Singapore (IPOS) have announced proposed changes to Singapore’s patents regime which they are seeking public feedback on until 1 August 2017.
